Gary I. Sinclair, MD

Physician
PrismHealth North Texas

Disclosure(s): ABBVIE: Grant/Research Support; Gilead: Grant/Research Support; Janssen: Advisor/Consultant, Grant/Research Support, Honoraria; Merck: Grant/Research Support; Thera: Grant/Research Support, Honoraria; ViiV/GSK: Advisor/Consultant, Grant/Research Support, Honoraria

Poster(s):

• 1288 - US Healthcare Provider Perspectives on the initiation of cabotegravir and rilpivirine long-acting (CAB+RPV LA) in an observational real-world study (BEYOND)
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET